The largest database of trusted experimental protocols

Amersham ecltm blocking agent

Manufactured by GE Healthcare
Sourced in United Kingdom

The Amersham™ ECL™ Blocking Agent is a specialized reagent used in Western blotting techniques. It is designed to reduce non-specific binding of antibodies, helping to improve the signal-to-noise ratio and enhance the specificity of the immunodetection process.

Automatically generated - may contain errors

2 protocols using amersham ecltm blocking agent

1

Western Blot Analysis of Mist1 Overexpression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fetal hepatoblasts infected with mock or Mist1-overexpressing retrovirus were washed with PBS and lysed with RIPA buffer (20 mM TrisHCl pH7.4, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.1% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS], and 1× Complete Protease Inhibitor Cocktail). The protein lysates were mixed with SDS sample loading buffer containing β-mercaptoethanol, electrophoresed on a 15% SDS-polyacrylamide gel, and electrotransferred onto an Immobilon-P membrane (Millipore, Billerica, MA, USA). The membrane was blocked with PBS with Tween 20 (PBS-T) containing 5% AmershamTM ECLTM Blocking Agent (GE healthcare UK Ltd., Backinghamshire, England) overnight, then incubated with primary antibody, Mist1 antibody (Thermoscientific, Waltham, MA, USA), in blocking buffer for 2 hr. Then, the membrane was washed with PBS-T and incubated with a horseradish peroxidase-conjugated secondary antibody (Millipore). After another wash with PBS-T, immunoreactive protein was developed by the ECL reagent (Millipore) and the chemiluminescence was captured with an ATTO Ez-Capture MG AE-9300 (ATTO Corporation, Tokyo, Japan).
+ Open protocol
+ Expand
2

Nuclear Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nuclear extracts were prepared from livers or hepatocytes using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific) according to the manufacture's protocol. Nuclear extracts were mixed with SDS sample loading buffer (Wako Pure Chemical Corporation, Osaka, Japan), electrophoresed using a Super-Sep TM Ace 10% gel (Wako Pure Chemical Corporation), and then electrotransferred onto an Immobilon-P membrane (Millipore, Billerica, MA). The membrane was blocked overnight in phosphate buffered saline (PBS) with Tween 20 (PBS-T) containing 3% or 5% Amersham TM ECL TM Blocking Agent (GE healthcare UK Ltd.) and then incubated with primary antibody-Bcl6 antibody (D-8; Santa Cruz Biotechnology, Dallas, TX)-for 2 h. Next, the membrane was washed with PBS-T and incubated with horseradish peroxidase-conjugated secondary antibody (Millipore). During incubation with primary and secondary antibodies, western blot immune booster solutions (Takara Bio Inc., Shiga, Japan) were used to enhance antibody interactions. After another wash with PBS-T, immunoreactive proteins were developed by the ECL reagent (Takara Bio Inc.) and chemiluminescence was captured using the Image Quant LAS 500 (GE healthcare UK Ltd.).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!